Merit Medical Systems Non-GAAP EPS of 0.77 beats by 0.05, revenue of 323.51M beats
| ICSSX Fund | USD 18.37 0.00 0.00% |
Slightly above 55% of Vy(r) Columbia's investor base is interested to short. The analysis of overall sentiment of trading Vy Umbia Small mutual fund suggests that many investors are impartial at this time. Vy(r) Columbia's investing sentiment can be driven by a variety of factors including economic data, Vy(r) Columbia's earnings reports, geopolitical events, and overall market trends.
Vy(r) |
Merit Medical Systems reported better-than-expected Q1 results, with non-GAAP EPS beating estimates by 0.05 and revenue surpassing expectations by 7.59M.
Read at seekingalpha.com
 |
Vy(r) Columbia Fundamental Analysis
We analyze Vy(r) Columbia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vy(r) Columbia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vy(r) Columbia based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Vy Umbia is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Vy Umbia Small Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vy(r) Columbia mutual fund to make a market-neutral strategy. Peer analysis of Vy(r) Columbia could also be used in its relative valuation, which is a method of valuing Vy(r) Columbia by comparing valuation metrics with similar companies.
Peers
Vy(r) Columbia Related Equities
| ILABX | Voya Us | 0.11 | ||||
| ILUAX | Voya Us | 0.11 | ||||
| ILBPX | Voya Limited | 0.00 | ||||
| ILBAX | Voya Us | 0.00 | ||||
| IMBAX | Voya Limited | 0.00 | ||||
| IMCDX | Voya Emerging | 0.00 | ||||
| IMOPX | Voya Midcap | 0.00 | ||||
| ILMBX | Voya Limited | 0.00 | ||||
| IMORX | Voya Midcap | 0.05 | ||||
| IMCVX | Voya Multi-manager | 0.35 |
Other Information on Investing in Vy(r) Mutual Fund
Vy(r) Columbia financial ratios help investors to determine whether Vy(r) Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vy(r) with respect to the benefits of owning Vy(r) Columbia security.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |